» Articles » PMID: 20875294

Pandemic (H1N1) 2009 and Seasonal Influenza A (H1N1) Co-infection, New Zealand, 2009

Overview
Date 2010 Sep 30
PMID 20875294
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Co-infection with seasonal influenza A (H1N1) and pandemic (H1N1) 2009 could result in reassortant viruses that may acquire new characteristics of transmission, virulence, and oseltamivir susceptibility. Results from oseltamivir-sensitivity testing on viral culture suggested the possibility of co-infections with oseltamivir-resistant (seasonal A [H1N1]) and -susceptible (pandemic [H1N1] 2009) viruses.

Citing Articles

Towards Understanding and Identification of Human Viral Co-Infections.

Wu H, Zhou H, Zheng H, Wu A Viruses. 2024; 16(5).

PMID: 38793555 PMC: 11126107. DOI: 10.3390/v16050673.


High-throughput droplet-based analysis of influenza A virus genetic reassortment by single-virus RNA sequencing.

Chen K, Karuppusamy J, ONeill M, Opuu V, Bahin M, Foulon S Proc Natl Acad Sci U S A. 2023; 120(6):e2211098120.

PMID: 36730204 PMC: 9963642. DOI: 10.1073/pnas.2211098120.


New endemic and pandemic pathologies with interhuman airborne transmission through ear, nose and throat anatomical sites.

Di Gennaro F, Petrosillo N Acta Otorhinolaryngol Ital. 2022; 42(Suppl. 1):S5-S13.

PMID: 35763270 PMC: 9137375. DOI: 10.14639/0392-100X-suppl.1-42-2022-01.


A Mathematical Modeling Study: Assessing Impact of Mismatch Between Influenza Vaccine Strains and Circulating Strains in Hajj.

Alharbi M, Kribs C Bull Math Biol. 2021; 83(1):7.

PMID: 33387065 PMC: 7778428. DOI: 10.1007/s11538-020-00836-6.


Atypical antibody responses to influenza.

Hermans D, Webby R, Wong S J Thorac Dis. 2018; 10(Suppl 19):S2238-S2247.

PMID: 30116603 PMC: 6072921. DOI: 10.21037/jtd.2017.12.122.


References
1.
Peacey M, Hall R, Bocacao J, Huang Q . Diagnostic assay recommended by the world health organization for swine origin influenza a (h1n1) virus cross-reacts with H5N1 influenza virus. J Clin Microbiol. 2009; 47(11):3789-90. PMC: 2772606. DOI: 10.1128/JCM.01509-09. View

2.
Toda S, Okamoto R, Nishida T, Nakao T, Yoshikawa M, Suzuki E . Isolation of influenza A/H3 and B viruses from an influenza patient: confirmation of co-infection by two influenza viruses. Jpn J Infect Dis. 2006; 59(2):142-3. View

3.
Eshaghi A, Blair J, Burton L, Choi K, De Lima C, Duncan C . Characterization of an influenza A and influenza B co-infection of a patient in a long-term care facility with co-circulating influenza A and influenza B. Int J Infect Dis. 2008; 13(3):e127-8. DOI: 10.1016/j.ijid.2008.06.024. View

4.
Hurt A, Barr I, Hartel G, Hampson A . Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir. Antiviral Res. 2004; 62(1):37-45. DOI: 10.1016/j.antiviral.2003.11.008. View

5.
Falchi A, Arena C, Andreoletti L, Jacques J, Leveque N, Blanchon T . Dual infections by influenza A/H3N2 and B viruses and by influenza A/H3N2 and A/H1N1 viruses during winter 2007, Corsica Island, France. J Clin Virol. 2007; 41(2):148-51. DOI: 10.1016/j.jcv.2007.11.003. View